Adverse reactions were generally mild and occurred at an incidence similar to placebo (vehicle). The most frequently reported event was transient ocular discomfort (burning/stinging). Other reported events included headache, keratitis, ocular pruritus, ocular hyperemia, pharyngitis and subconjunctival haemorrhage which were reported at an incidence.
View ADR Monitoring Form